Isoliquiritigenin inhibits proliferation and induces apoptosis of U87 human glioma cells in vitro

Molecular Medicine Reports

Volumn 7, Issue 2, 2013, Pages 531-536

  Zhou, Guo Sheng ^a   Song, Lai Jun ^a   Yang, Bo ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Apoptosis; Caspase; Cell cycle; Glioma; Isoliquiritigenin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CYCLIN DEPENDENT KINASE INHIBITOR 1; ISOLIQUIRITIGENIN; PROTEIN P21; PROTEIN P27;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL ASSAY; CELL CYCLE PROGRESSION; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME ACTIVATION; FLUORESCENCE ACTIVATED CELL SORTING; G2 PHASE CELL CYCLE CHECKPOINT; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; M PHASE CELL CYCLE CHECKPOINT; PROTEIN EXPRESSION; S PHASE CELL CYCLE CHECKPOINT; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

AMINO ACID CHLOROMETHYL KETONES; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CHALCONES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; ENZYME ACTIVATION; GLIOMA; HUMANS; UP-REGULATION;

EID: 84873857035     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1218     Document Type: Article

References (20)

1. Lima FR, Kahn SA, Soletti RC, Biasoli D, Alves T, daFonseca AC, et al: Glioblastoma: Therapeutic challenges, what lies ahead. Biochim Biophys Acta 1826: 338-349, 2012.
2. Ma X, Lv Y, Liu J, Wang D, Huang Q, Wang X, Li G, Xu S and Li X: Survival analysis of 205 patients with glioblastoma multiforme: clinical characteristics, treatment and prognosis in China. J Clin Neurosci 16: 1595-1598, 2009.
3. Davis ME and Stoiber AM: Glioblastoma multiforme: enhancing survival and quality of life. Clin J Oncol Nurs 15: 291-297, 2011.
4. Lin H, Liu J and Zhang Y: Developments in cancer prevention and treatment using traditional Chinese medicine. Front Med5: 127-133, 2011.
5. Efferth T, Li PC, Konkimalla VS and Kaina B: From traditional Chinese medicine to rational cancer therapy. Trends Mol Med 13: 353-361, 2007.
6. Wang S, Wu X, Tan M, Gong J, Tan W, Bian B, Chen M and Wang Y: Fighting fire with fire: poisonous Chinese herbal medicine for cancer therapy. J Ethnopharmacol 140: 33-45, 2012.
7. Kandaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, Huang YT and Lee MT: The antitumor activities of flavonoids. In Vivo 19: 895-909, 2005.
8. Weng CJ and Yen GC: Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities. Cancer Metastasis Rev 31: 323-351, 2012.
9. Lee CK, Son SH, Park KK, Park JH, Lim SS and Chung WY: Isoliquiritigenin inhibits tumor growth and protects the kidney and liver against chemotherapy-induced toxicity in a mouse xenograft model of colon carcinoma. J Pharmacol Sci106: 444-451, 2008.
10. Orlikova B, Schnekenburger M, Zloh M, Golais F, Diederich M and Tasdemir D: Natural chalcones as dual inhibitors of HDACs and NF-κB. Oncol Rep 28: 797-805, 2012.
11. Lee YM, Jeong GS, Lim HD, An RB, Kim YC and Kim EC: Isoliquiritigenin 2-methyl ether induces growth inhibition and apoptosis in oral cancer cells via heme oxygenase-1. Toxicol In Vitro 24: 776-782, 2010.
12. Auyeung KK and Ko JK: Novel herbal flavonoids promote apoptosis but differentially induce cell cycle arrest in human colon cancer cell. Invest New Drugs 28: 1-13, 2010.
13. Lau GT, Ye L and Leung LK: The licorice flavonoid isoliquiritigenin suppresses phorbol ester-induced cyclooxygenase-2 expression in the non-tumorigenic MCF-10A breast cell line. Planta Med 76: 780-785, 2010.
14. Ye L, Gho WM, Chan FL, Chen S and Leung LK: Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF-7 cells overexpressing aromatase. Int J Cancer 124: 1028-1036, 2009.
15. Ma J, Fu NY, Pang DB, Wu WY and Xu AL: Apoptosis induced by isoliquiritigenin in human gastric cancer MGC-803 cells. Planta Med 67: 754-777, 2001.
16. Zhang X, Yeung ED, Wang J, Panzhinskiy EE, Tong C, Li W and Li J: Isoliquiritigenin, a natural anti-oxidant, selectively inhibits the proliferation of prostate cancer cells. Clin Exp Pharmacol Physiol 37: 841-847, 2010.
17. Iwashita K, Kobori M, Yamaki K and Tsushida T: Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. Biosci Biotechnol Biochem 64: 1813-1820, 2000.
18. Hsu YL, Kuo PL, Chiang LC and Lin CC: Isoliquiritigenin inhibits the proliferation and induces the apoptosis of human non-small cell lung cancer A549 cells. Clin Exp Pharmacol Physiol 31: 414-418, 2004.
19. Li T, Satomi Y, Kotoh D, Shimada J, Baba M, Okuyama T, Nishino H and Kitamura N: Induction of cell cycle arrest and p21(CIP1/WAF1) expression in human lung cancer cells by isoliquiritigenin. Cancer Lett 207: 27-35, 2004.
20. Lee YM, Lim do Y, Choi HJ, Jung JL, Chung WY and Park JH: Induction of cell cycle arrest in prostate cancer cells by the dietary compound isoliquiritigenin. J Med Food 12: 8-14, 2009.